Peptide Therapeutics Market

Peptide Therapeutics Market - Global Industry Assessment & Forecast

Healthcare

# Pages:

230

Base Year:

2023

Feb - 2024

Format:

Report Code:

VMR-2350

Segments Covered

By Type Branded Peptides, Generic Peptides
By Application Metabolic Disorders, Cancer, Cardiovascular Disorders, Gastrointestinal Disorders, Central Nervous System Disorders, Respiratory Disorders, Pain Management, Rental Disorders, Dermatology, Other Applications
By Route of Administration Parenteral, Oral, Other Routes of Administration
By Manufacturer Type In-house, Outsourced
By Synthesis Technology Liquid Phase Peptide Synthesis (LPPS), Solid Phase Peptide Synthesis (SPPS), Hybrid Technology
By Distribution Channel Hospital Pharmacies, Retail Pharmacies, Online Pharmacies
By Region North America, Europe, Asia Pacific, Latin America, Middle East & Africa

Standard License

$ 4299 USD

Multi User License

$ 6599 USD

Enterprise License

$ 6999 USD

Snapshot

Base Year:	2023
Forecast Years:	2024 - 2032
Historical Years:	2018 - 2022
Revenue 2023:	USD 43.04 Billion
Revenue 2032:	USD 81.48 Billion
Revenue CAGR (2024 - 2032):	7.35%
Fastest Growing Region (2024 - 2032)	Asia Pacific
Largest Region (2023):	North America

Customization Offered

Cross-segment Market Size and Analysis for Mentioned Segments
Additional Company Profiles (Upto 5 With No Cost)
Additional Countries (Apart From Mentioned Countries)
Country/Region-specific Report
Go To Market Strategy
Region Specific Market Dynamics
Region Level Market Share
Import Export Analysis
Production Analysis
Others Request Customization Speak To Analyst

Executive Dashboard
1. Strategic Imperatives
Premium Insights
1. Top 3 Trends to Watch
2. Demand and Supply Trends
3. Top 3 Strategies Followed by Major Players
4. Top 3 Predictions by Vantage Market Research
5. Top Investment Pockets
6. Insights from Primary Respondents
Global Peptide Therapeutics Market - Segment Analysis
1. Overview
2. Global Peptide Therapeutics Market, 2016 - 2028 (USD Million)
3. Global Peptide Therapeutics Market - by Type
  1. By Branded Peptides
  2. By Generic Peptides
4. Global Peptide Therapeutics Market - by Application
  1. By Metabolic Disorders
  2. By Cancer
  3. By Cardiovascular Disorders
  4. By Gastrointestinal Disorders
  5. By Central Nervous System Disorders
  6. By Respiratory Disorders
  7. By Pain Management
  8. By Rental Disorders
  9. By Dermatology
  10. By Other Applications
5. Global Peptide Therapeutics Market - by Route of Administration
  1. By Parenteral
  2. By Oral
  3. By Other Routes of Administration
6. Global Peptide Therapeutics Market - by Manufacturer Type
  1. By In-house
  2. By Outsourced
7. Global Peptide Therapeutics Market - by Synthesis Technology
  1. By Liquid Phase Peptide Synthesis (LPPS)
  2. By Solid Phase Peptide Synthesis (SPPS)
  3. By Hybrid Technology
8. Global Peptide Therapeutics Market - by Distribution Channel
  1. By Hospital Pharmacies
  2. By Retail Pharmacies
  3. By Online Pharmacies
9. Global Peptide Therapeutics Market - by region
  1. North America
  2. Europe
  3. Asia Pacific
  4. Latin America
  5. Middle East & Africa
10. Market comparative analysis
North America Peptide Therapeutics Market - Segment Analysis
1. Overview
2. North America Peptide Therapeutics Market, 2016 - 2028 (USD Million)
3. North America Peptide Therapeutics Market, by Type
  1. By Branded Peptides
  2. By Generic Peptides
4. North America Peptide Therapeutics Market, by Application
  1. By Metabolic Disorders
  2. By Cancer
  3. By Cardiovascular Disorders
  4. By Gastrointestinal Disorders
  5. By Central Nervous System Disorders
  6. By Respiratory Disorders
  7. By Pain Management
  8. By Rental Disorders
  9. By Dermatology
  10. By Other Applications
5. North America Peptide Therapeutics Market, by Route of Administration
  1. By Parenteral
  2. By Oral
  3. By Other Routes of Administration
6. North America Peptide Therapeutics Market, by Manufacturer Type
  1. By In-house
  2. By Outsourced
7. North America Peptide Therapeutics Market, by Synthesis Technology
  1. By Liquid Phase Peptide Synthesis (LPPS)
  2. By Solid Phase Peptide Synthesis (SPPS)
  3. By Hybrid Technology
8. North America Peptide Therapeutics Market, by Distribution Channel
  1. By Hospital Pharmacies
  2. By Retail Pharmacies
  3. By Online Pharmacies
9. North America Peptide Therapeutics Market, by Country
  1. U.S.
    1. U.S. Peptide Therapeutics Market, By Type
      1. By Branded Peptides
      2. By Generic Peptides
    2. U.S. Peptide Therapeutics Market, By Application
      1. By Metabolic Disorders
      2. By Cancer
      3. By Cardiovascular Disorders
      4. By Gastrointestinal Disorders
      5. By Central Nervous System Disorders
      6. By Respiratory Disorders
      7. By Pain Management
      8. By Rental Disorders
      9. By Dermatology
      10. By Other Applications
    3. U.S. Peptide Therapeutics Market, By Route of Administration
      1. By Parenteral
      2. By Oral
      3. By Other Routes of Administration
    4. U.S. Peptide Therapeutics Market, By Manufacturer Type
      1. By In-house
      2. By Outsourced
    5. U.S. Peptide Therapeutics Market, By Synthesis Technology
      1. By Liquid Phase Peptide Synthesis (LPPS)
      2. By Solid Phase Peptide Synthesis (SPPS)
      3. By Hybrid Technology
    6. U.S. Peptide Therapeutics Market, By Distribution Channel
      1. By Hospital Pharmacies
      2. By Retail Pharmacies
      3. By Online Pharmacies
  2. Canada
    1. Canada Peptide Therapeutics Market, By Type
      1. By Branded Peptides
      2. By Generic Peptides
    2. Canada Peptide Therapeutics Market, By Application
      1. By Metabolic Disorders
      2. By Cancer
      3. By Cardiovascular Disorders
      4. By Gastrointestinal Disorders
      5. By Central Nervous System Disorders
      6. By Respiratory Disorders
      7. By Pain Management
      8. By Rental Disorders
      9. By Dermatology
      10. By Other Applications
    3. Canada Peptide Therapeutics Market, By Route of Administration
      1. By Parenteral
      2. By Oral
      3. By Other Routes of Administration
    4. Canada Peptide Therapeutics Market, By Manufacturer Type
      1. By In-house
      2. By Outsourced
    5. Canada Peptide Therapeutics Market, By Synthesis Technology
      1. By Liquid Phase Peptide Synthesis (LPPS)
      2. By Solid Phase Peptide Synthesis (SPPS)
      3. By Hybrid Technology
    6. Canada Peptide Therapeutics Market, By Distribution Channel
      1. By Hospital Pharmacies
      2. By Retail Pharmacies
      3. By Online Pharmacies
  3. Mexico
    1. Mexico Peptide Therapeutics Market, By Type
      1. By Branded Peptides
      2. By Generic Peptides
    2. Mexico Peptide Therapeutics Market, By Application
      1. By Metabolic Disorders
      2. By Cancer
      3. By Cardiovascular Disorders
      4. By Gastrointestinal Disorders
      5. By Central Nervous System Disorders
      6. By Respiratory Disorders
      7. By Pain Management
      8. By Rental Disorders
      9. By Dermatology
      10. By Other Applications
    3. Mexico Peptide Therapeutics Market, By Route of Administration
      1. By Parenteral
      2. By Oral
      3. By Other Routes of Administration
    4. Mexico Peptide Therapeutics Market, By Manufacturer Type
      1. By In-house
      2. By Outsourced
    5. Mexico Peptide Therapeutics Market, By Synthesis Technology
      1. By Liquid Phase Peptide Synthesis (LPPS)
      2. By Solid Phase Peptide Synthesis (SPPS)
      3. By Hybrid Technology
    6. Mexico Peptide Therapeutics Market, By Distribution Channel
      1. By Hospital Pharmacies
      2. By Retail Pharmacies
      3. By Online Pharmacies
Europe Peptide Therapeutics Market - Segment Analysis
1. Overview
2. Europe Peptide Therapeutics Market, 2016 - 2028 (USD Million)
3. Europe Peptide Therapeutics Market, by Type
  1. By Branded Peptides
  2. By Generic Peptides
4. Europe Peptide Therapeutics Market, by Application
  1. By Metabolic Disorders
  2. By Cancer
  3. By Cardiovascular Disorders
  4. By Gastrointestinal Disorders
  5. By Central Nervous System Disorders
  6. By Respiratory Disorders
  7. By Pain Management
  8. By Rental Disorders
  9. By Dermatology
  10. By Other Applications
5. Europe Peptide Therapeutics Market, by Route of Administration
  1. By Parenteral
  2. By Oral
  3. By Other Routes of Administration
6. Europe Peptide Therapeutics Market, by Manufacturer Type
  1. By In-house
  2. By Outsourced
7. Europe Peptide Therapeutics Market, by Synthesis Technology
  1. By Liquid Phase Peptide Synthesis (LPPS)
  2. By Solid Phase Peptide Synthesis (SPPS)
  3. By Hybrid Technology
8. Europe Peptide Therapeutics Market, by Distribution Channel
  1. By Hospital Pharmacies
  2. By Retail Pharmacies
  3. By Online Pharmacies
9. Europe Peptide Therapeutics Market, by Country
  1. Germany
    1. Germany Peptide Therapeutics Market, By Type
      1. By Branded Peptides
      2. By Generic Peptides
    2. Germany Peptide Therapeutics Market, By Application
      1. By Metabolic Disorders
      2. By Cancer
      3. By Cardiovascular Disorders
      4. By Gastrointestinal Disorders
      5. By Central Nervous System Disorders
      6. By Respiratory Disorders
      7. By Pain Management
      8. By Rental Disorders
      9. By Dermatology
      10. By Other Applications
    3. Germany Peptide Therapeutics Market, By Route of Administration
      1. By Parenteral
      2. By Oral
      3. By Other Routes of Administration
    4. Germany Peptide Therapeutics Market, By Manufacturer Type
      1. By In-house
      2. By Outsourced
    5. Germany Peptide Therapeutics Market, By Synthesis Technology
      1. By Liquid Phase Peptide Synthesis (LPPS)
      2. By Solid Phase Peptide Synthesis (SPPS)
      3. By Hybrid Technology
    6. Germany Peptide Therapeutics Market, By Distribution Channel
      1. By Hospital Pharmacies
      2. By Retail Pharmacies
      3. By Online Pharmacies
  2. UK
    1. UK Market, By Type
      1. By Branded Peptides
      2. By Generic Peptides
    2. UK Market, By Application
      1. By Metabolic Disorders
      2. By Cancer
      3. By Cardiovascular Disorders
      4. By Gastrointestinal Disorders
      5. By Central Nervous System Disorders
      6. By Respiratory Disorders
      7. By Pain Management
      8. By Rental Disorders
      9. By Dermatology
      10. By Other Applications
    3. UK Market, By Route of Administration
      1. By Parenteral
      2. By Oral
      3. By Other Routes of Administration
    4. UK Market, By Manufacturer Type
      1. By In-house
      2. By Outsourced
    5. UK Market, By Synthesis Technology
      1. By Liquid Phase Peptide Synthesis (LPPS)
      2. By Solid Phase Peptide Synthesis (SPPS)
      3. By Hybrid Technology
    6. UK Market, By Distribution Channel
      1. By Hospital Pharmacies
      2. By Retail Pharmacies
      3. By Online Pharmacies
  3. France
    1. France Peptide Therapeutics Market, By Type
      1. By Branded Peptides
      2. By Generic Peptides
    2. France Peptide Therapeutics Market, By Application
      1. By Metabolic Disorders
      2. By Cancer
      3. By Cardiovascular Disorders
      4. By Gastrointestinal Disorders
      5. By Central Nervous System Disorders
      6. By Respiratory Disorders
      7. By Pain Management
      8. By Rental Disorders
      9. By Dermatology
      10. By Other Applications
    3. France Peptide Therapeutics Market, By Route of Administration
      1. By Parenteral
      2. By Oral
      3. By Other Routes of Administration
    4. France Peptide Therapeutics Market, By Manufacturer Type
      1. By In-house
      2. By Outsourced
    5. France Peptide Therapeutics Market, By Synthesis Technology
      1. By Liquid Phase Peptide Synthesis (LPPS)
      2. By Solid Phase Peptide Synthesis (SPPS)
      3. By Hybrid Technology
    6. France Peptide Therapeutics Market, By Distribution Channel
      1. By Hospital Pharmacies
      2. By Retail Pharmacies
      3. By Online Pharmacies
  4. Spain
    1. Spain Peptide Therapeutics Market, By Type
      1. By Branded Peptides
      2. By Generic Peptides
    2. Spain Peptide Therapeutics Market, By Application
      1. By Metabolic Disorders
      2. By Cancer
      3. By Cardiovascular Disorders
      4. By Gastrointestinal Disorders
      5. By Central Nervous System Disorders
      6. By Respiratory Disorders
      7. By Pain Management
      8. By Rental Disorders
      9. By Dermatology
      10. By Other Applications
    3. Spain Peptide Therapeutics Market, By Route of Administration
      1. By Parenteral
      2. By Oral
      3. By Other Routes of Administration
    4. Spain Peptide Therapeutics Market, By Manufacturer Type
      1. By In-house
      2. By Outsourced
    5. Spain Peptide Therapeutics Market, By Synthesis Technology
      1. By Liquid Phase Peptide Synthesis (LPPS)
      2. By Solid Phase Peptide Synthesis (SPPS)
      3. By Hybrid Technology
    6. Spain Peptide Therapeutics Market, By Distribution Channel
      1. By Hospital Pharmacies
      2. By Retail Pharmacies
      3. By Online Pharmacies
  5. Italy
    1. Italy Peptide Therapeutics Market, By Type
      1. By Branded Peptides
      2. By Generic Peptides
    2. Italy Peptide Therapeutics Market, By Application
      1. By Metabolic Disorders
      2. By Cancer
      3. By Cardiovascular Disorders
      4. By Gastrointestinal Disorders
      5. By Central Nervous System Disorders
      6. By Respiratory Disorders
      7. By Pain Management
      8. By Rental Disorders
      9. By Dermatology
      10. By Other Applications
    3. Italy Peptide Therapeutics Market, By Route of Administration
      1. By Parenteral
      2. By Oral
      3. By Other Routes of Administration
    4. Italy Peptide Therapeutics Market, By Manufacturer Type
      1. By In-house
      2. By Outsourced
    5. Italy Peptide Therapeutics Market, By Synthesis Technology
      1. By Liquid Phase Peptide Synthesis (LPPS)
      2. By Solid Phase Peptide Synthesis (SPPS)
      3. By Hybrid Technology
    6. Italy Peptide Therapeutics Market, By Distribution Channel
      1. By Hospital Pharmacies
      2. By Retail Pharmacies
      3. By Online Pharmacies
  6. BENELUX
    1. BENELUX Peptide Therapeutics Market, By Type
      1. By Branded Peptides
      2. By Generic Peptides
    2. BENELUX Peptide Therapeutics Market, By Application
      1. By Metabolic Disorders
      2. By Cancer
      3. By Cardiovascular Disorders
      4. By Gastrointestinal Disorders
      5. By Central Nervous System Disorders
      6. By Respiratory Disorders
      7. By Pain Management
      8. By Rental Disorders
      9. By Dermatology
      10. By Other Applications
    3. BENELUX Peptide Therapeutics Market, By Route of Administration
      1. By Parenteral
      2. By Oral
      3. By Other Routes of Administration
    4. BENELUX Peptide Therapeutics Market, By Manufacturer Type
      1. By In-house
      2. By Outsourced
    5. BENELUX Peptide Therapeutics Market, By Synthesis Technology
      1. By Liquid Phase Peptide Synthesis (LPPS)
      2. By Solid Phase Peptide Synthesis (SPPS)
      3. By Hybrid Technology
    6. BENELUX Peptide Therapeutics Market, By Distribution Channel
      1. By Hospital Pharmacies
      2. By Retail Pharmacies
      3. By Online Pharmacies
  7. Rest of Europe
    1. Rest Of Europe Peptide Therapeutics Market, By Type
      1. By Branded Peptides
      2. By Generic Peptides
    2. Rest Of Europe Peptide Therapeutics Market, By Application
      1. By Metabolic Disorders
      2. By Cancer
      3. By Cardiovascular Disorders
      4. By Gastrointestinal Disorders
      5. By Central Nervous System Disorders
      6. By Respiratory Disorders
      7. By Pain Management
      8. By Rental Disorders
      9. By Dermatology
      10. By Other Applications
    3. Rest Of Europe Peptide Therapeutics Market, By Route of Administration
      1. By Parenteral
      2. By Oral
      3. By Other Routes of Administration
    4. Rest Of Europe Peptide Therapeutics Market, By Manufacturer Type
      1. By In-house
      2. By Outsourced
    5. Rest Of Europe Peptide Therapeutics Market, By Synthesis Technology
      1. By Liquid Phase Peptide Synthesis (LPPS)
      2. By Solid Phase Peptide Synthesis (SPPS)
      3. By Hybrid Technology
    6. Rest Of Europe Peptide Therapeutics Market, By Distribution Channel
      1. By Hospital Pharmacies
      2. By Retail Pharmacies
      3. By Online Pharmacies
Asia Pacific Peptide Therapeutics Market - Segment Analysis
1. Overview
2. Asia Pacific Peptide Therapeutics Market, 2016 - 2028 (USD Million)
3. Asia Pacific Peptide Therapeutics Market, by Type
  1. By Branded Peptides
  2. By Generic Peptides
4. Asia Pacific Peptide Therapeutics Market, by Application
  1. By Metabolic Disorders
  2. By Cancer
  3. By Cardiovascular Disorders
  4. By Gastrointestinal Disorders
  5. By Central Nervous System Disorders
  6. By Respiratory Disorders
  7. By Pain Management
  8. By Rental Disorders
  9. By Dermatology
  10. By Other Applications
5. Asia Pacific Peptide Therapeutics Market, by Route of Administration
  1. By Parenteral
  2. By Oral
  3. By Other Routes of Administration
6. Asia Pacific Peptide Therapeutics Market, by Manufacturer Type
  1. By In-house
  2. By Outsourced
7. Asia Pacific Peptide Therapeutics Market, by Synthesis Technology
  1. By Liquid Phase Peptide Synthesis (LPPS)
  2. By Solid Phase Peptide Synthesis (SPPS)
  3. By Hybrid Technology
8. Asia Pacific Peptide Therapeutics Market, by Distribution Channel
  1. By Hospital Pharmacies
  2. By Retail Pharmacies
  3. By Online Pharmacies
9. Asia Pacific Peptide Therapeutics Market, by Country
  1. China
    1. China Peptide Therapeutics Market, By Type
      1. By Branded Peptides
      2. By Generic Peptides
    2. China Peptide Therapeutics Market, By Application
      1. By Metabolic Disorders
      2. By Cancer
      3. By Cardiovascular Disorders
      4. By Gastrointestinal Disorders
      5. By Central Nervous System Disorders
      6. By Respiratory Disorders
      7. By Pain Management
      8. By Rental Disorders
      9. By Dermatology
      10. By Other Applications
    3. China Peptide Therapeutics Market, By Route of Administration
      1. By Parenteral
      2. By Oral
      3. By Other Routes of Administration
    4. China Peptide Therapeutics Market, By Manufacturer Type
      1. By In-house
      2. By Outsourced
    5. China Peptide Therapeutics Market, By Synthesis Technology
      1. By Liquid Phase Peptide Synthesis (LPPS)
      2. By Solid Phase Peptide Synthesis (SPPS)
      3. By Hybrid Technology
    6. China Peptide Therapeutics Market, By Distribution Channel
      1. By Hospital Pharmacies
      2. By Retail Pharmacies
      3. By Online Pharmacies
  2. Japan
    1. Japan Peptide Therapeutics Market, By Type
      1. By Branded Peptides
      2. By Generic Peptides
    2. Japan Peptide Therapeutics Market, By Application
      1. By Metabolic Disorders
      2. By Cancer
      3. By Cardiovascular Disorders
      4. By Gastrointestinal Disorders
      5. By Central Nervous System Disorders
      6. By Respiratory Disorders
      7. By Pain Management
      8. By Rental Disorders
      9. By Dermatology
      10. By Other Applications
    3. Japan Peptide Therapeutics Market, By Route of Administration
      1. By Parenteral
      2. By Oral
      3. By Other Routes of Administration
    4. Japan Peptide Therapeutics Market, By Manufacturer Type
      1. By In-house
      2. By Outsourced
    5. Japan Peptide Therapeutics Market, By Synthesis Technology
      1. By Liquid Phase Peptide Synthesis (LPPS)
      2. By Solid Phase Peptide Synthesis (SPPS)
      3. By Hybrid Technology
    6. Japan Peptide Therapeutics Market, By Distribution Channel
      1. By Hospital Pharmacies
      2. By Retail Pharmacies
      3. By Online Pharmacies
  3. India
    1. India Peptide Therapeutics Market, By Type
      1. By Branded Peptides
      2. By Generic Peptides
    2. India Peptide Therapeutics Market, By Application
      1. By Metabolic Disorders
      2. By Cancer
      3. By Cardiovascular Disorders
      4. By Gastrointestinal Disorders
      5. By Central Nervous System Disorders
      6. By Respiratory Disorders
      7. By Pain Management
      8. By Rental Disorders
      9. By Dermatology
      10. By Other Applications
    3. India Peptide Therapeutics Market, By Route of Administration
      1. By Parenteral
      2. By Oral
      3. By Other Routes of Administration
    4. India Peptide Therapeutics Market, By Manufacturer Type
      1. By In-house
      2. By Outsourced
    5. India Peptide Therapeutics Market, By Synthesis Technology
      1. By Liquid Phase Peptide Synthesis (LPPS)
      2. By Solid Phase Peptide Synthesis (SPPS)
      3. By Hybrid Technology
    6. India Peptide Therapeutics Market, By Distribution Channel
      1. By Hospital Pharmacies
      2. By Retail Pharmacies
      3. By Online Pharmacies
  4. South Korea
    1. South Korea Peptide Therapeutics Market, By Type
      1. By Branded Peptides
      2. By Generic Peptides
    2. South Korea Peptide Therapeutics Market, By Application
      1. By Metabolic Disorders
      2. By Cancer
      3. By Cardiovascular Disorders
      4. By Gastrointestinal Disorders
      5. By Central Nervous System Disorders
      6. By Respiratory Disorders
      7. By Pain Management
      8. By Rental Disorders
      9. By Dermatology
      10. By Other Applications
    3. South Korea Peptide Therapeutics Market, By Route of Administration
      1. By Parenteral
      2. By Oral
      3. By Other Routes of Administration
    4. South Korea Peptide Therapeutics Market, By Manufacturer Type
      1. By In-house
      2. By Outsourced
    5. South Korea Peptide Therapeutics Market, By Synthesis Technology
      1. By Liquid Phase Peptide Synthesis (LPPS)
      2. By Solid Phase Peptide Synthesis (SPPS)
      3. By Hybrid Technology
    6. South Korea Peptide Therapeutics Market, By Distribution Channel
      1. By Hospital Pharmacies
      2. By Retail Pharmacies
      3. By Online Pharmacies
  5. South East Asia
    1. South East Asia Peptide Therapeutics Market, By Type
      1. By Branded Peptides
      2. By Generic Peptides
    2. South East Asia Peptide Therapeutics Market, By Application
      1. By Metabolic Disorders
      2. By Cancer
      3. By Cardiovascular Disorders
      4. By Gastrointestinal Disorders
      5. By Central Nervous System Disorders
      6. By Respiratory Disorders
      7. By Pain Management
      8. By Rental Disorders
      9. By Dermatology
      10. By Other Applications
    3. South East Asia Peptide Therapeutics Market, By Route of Administration
      1. By Parenteral
      2. By Oral
      3. By Other Routes of Administration
    4. South East Asia Peptide Therapeutics Market, By Manufacturer Type
      1. By In-house
      2. By Outsourced
    5. South East Asia Peptide Therapeutics Market, By Synthesis Technology
      1. By Liquid Phase Peptide Synthesis (LPPS)
      2. By Solid Phase Peptide Synthesis (SPPS)
      3. By Hybrid Technology
    6. South East Asia Peptide Therapeutics Market, By Distribution Channel
      1. By Hospital Pharmacies
      2. By Retail Pharmacies
      3. By Online Pharmacies
  6. Rest of Asia Pacific
    1. Rest of Asia Pacific Peptide Therapeutics Market, By Type
      1. By Branded Peptides
      2. By Generic Peptides
    2. Rest of Asia Pacific Peptide Therapeutics Market, By Application
      1. By Metabolic Disorders
      2. By Cancer
      3. By Cardiovascular Disorders
      4. By Gastrointestinal Disorders
      5. By Central Nervous System Disorders
      6. By Respiratory Disorders
      7. By Pain Management
      8. By Rental Disorders
      9. By Dermatology
      10. By Other Applications
    3. Rest of Asia Pacific Peptide Therapeutics Market, By Route of Administration
      1. By Parenteral
      2. By Oral
      3. By Other Routes of Administration
    4. Rest of Asia Pacific Peptide Therapeutics Market, By Manufacturer Type
      1. By In-house
      2. By Outsourced
    5. Rest of Asia Pacific Peptide Therapeutics Market, By Synthesis Technology
      1. By Liquid Phase Peptide Synthesis (LPPS)
      2. By Solid Phase Peptide Synthesis (SPPS)
      3. By Hybrid Technology
    6. Rest of Asia Pacific Peptide Therapeutics Market, By Distribution Channel
      1. By Hospital Pharmacies
      2. By Retail Pharmacies
      3. By Online Pharmacies
Latin America Peptide Therapeutics Market - Segment Analysis
1. Overview
2. Latin America Peptide Therapeutics Market, 2016 - 2028 (USD Million)
3. Latin America Peptide Therapeutics Market, by Type
  1. By Branded Peptides
  2. By Generic Peptides
4. Latin America Peptide Therapeutics Market, by Application
  1. By Metabolic Disorders
  2. By Cancer
  3. By Cardiovascular Disorders
  4. By Gastrointestinal Disorders
  5. By Central Nervous System Disorders
  6. By Respiratory Disorders
  7. By Pain Management
  8. By Rental Disorders
  9. By Dermatology
  10. By Other Applications
5. Latin America Peptide Therapeutics Market, by Route of Administration
  1. By Parenteral
  2. By Oral
  3. By Other Routes of Administration
6. Latin America Peptide Therapeutics Market, by Manufacturer Type
  1. By In-house
  2. By Outsourced
7. Latin America Peptide Therapeutics Market, by Synthesis Technology
  1. By Liquid Phase Peptide Synthesis (LPPS)
  2. By Solid Phase Peptide Synthesis (SPPS)
  3. By Hybrid Technology
8. Latin America Peptide Therapeutics Market, by Distribution Channel
  1. By Hospital Pharmacies
  2. By Retail Pharmacies
  3. By Online Pharmacies
9. Latin America Peptide Therapeutics Market, by Country
  1. Brazil
    1. Brazil Peptide Therapeutics Market, By Type
      1. By Branded Peptides
      2. By Generic Peptides
    2. Brazil Peptide Therapeutics Market, By Application
      1. By Metabolic Disorders
      2. By Cancer
      3. By Cardiovascular Disorders
      4. By Gastrointestinal Disorders
      5. By Central Nervous System Disorders
      6. By Respiratory Disorders
      7. By Pain Management
      8. By Rental Disorders
      9. By Dermatology
      10. By Other Applications
    3. Brazil Peptide Therapeutics Market, By Route of Administration
      1. By Parenteral
      2. By Oral
      3. By Other Routes of Administration
    4. Brazil Peptide Therapeutics Market, By Manufacturer Type
      1. By In-house
      2. By Outsourced
    5. Brazil Peptide Therapeutics Market, By Synthesis Technology
      1. By Liquid Phase Peptide Synthesis (LPPS)
      2. By Solid Phase Peptide Synthesis (SPPS)
      3. By Hybrid Technology
    6. Brazil Peptide Therapeutics Market, By Distribution Channel
      1. By Hospital Pharmacies
      2. By Retail Pharmacies
      3. By Online Pharmacies
  2. Argentina
    1. Argentina Peptide Therapeutics Market, By Type
      1. By Branded Peptides
      2. By Generic Peptides
    2. Argentina Peptide Therapeutics Market, By Application
      1. By Metabolic Disorders
      2. By Cancer
      3. By Cardiovascular Disorders
      4. By Gastrointestinal Disorders
      5. By Central Nervous System Disorders
      6. By Respiratory Disorders
      7. By Pain Management
      8. By Rental Disorders
      9. By Dermatology
      10. By Other Applications
    3. Argentina Peptide Therapeutics Market, By Route of Administration
      1. By Parenteral
      2. By Oral
      3. By Other Routes of Administration
    4. Argentina Peptide Therapeutics Market, By Manufacturer Type
      1. By In-house
      2. By Outsourced
    5. Argentina Peptide Therapeutics Market, By Synthesis Technology
      1. By Liquid Phase Peptide Synthesis (LPPS)
      2. By Solid Phase Peptide Synthesis (SPPS)
      3. By Hybrid Technology
    6. Argentina Peptide Therapeutics Market, By Distribution Channel
      1. By Hospital Pharmacies
      2. By Retail Pharmacies
      3. By Online Pharmacies
  3. Rest of Latin America
    1. Rest of Latin America Peptide Therapeutics Market, By Type
      1. By Branded Peptides
      2. By Generic Peptides
    2. Rest of Latin America Peptide Therapeutics Market, By Application
      1. By Metabolic Disorders
      2. By Cancer
      3. By Cardiovascular Disorders
      4. By Gastrointestinal Disorders
      5. By Central Nervous System Disorders
      6. By Respiratory Disorders
      7. By Pain Management
      8. By Rental Disorders
      9. By Dermatology
      10. By Other Applications
    3. Rest of Latin America Peptide Therapeutics Market, By Route of Administration
      1. By Parenteral
      2. By Oral
      3. By Other Routes of Administration
    4. Rest of Latin America Peptide Therapeutics Market, By Manufacturer Type
      1. By In-house
      2. By Outsourced
    5. Rest of Latin America Peptide Therapeutics Market, By Synthesis Technology
      1. By Liquid Phase Peptide Synthesis (LPPS)
      2. By Solid Phase Peptide Synthesis (SPPS)
      3. By Hybrid Technology
    6. Rest of Latin America Peptide Therapeutics Market, By Distribution Channel
      1. By Hospital Pharmacies
      2. By Retail Pharmacies
      3. By Online Pharmacies
Middle East & Africa Peptide Therapeutics Market - Segment Analysis
1. Overview
2. Middle East & Africa Peptide Therapeutics Market, 2016 - 2028 (USD Million)
3. Middle East & Africa Peptide Therapeutics Market, by Type
  1. By Branded Peptides
  2. By Generic Peptides
4. Middle East & Africa Peptide Therapeutics Market, by Application
  1. By Metabolic Disorders
  2. By Cancer
  3. By Cardiovascular Disorders
  4. By Gastrointestinal Disorders
  5. By Central Nervous System Disorders
  6. By Respiratory Disorders
  7. By Pain Management
  8. By Rental Disorders
  9. By Dermatology
  10. By Other Applications
5. Middle East & Africa Peptide Therapeutics Market, by Route of Administration
  1. By Parenteral
  2. By Oral
  3. By Other Routes of Administration
6. Middle East & Africa Peptide Therapeutics Market, by Manufacturer Type
  1. By In-house
  2. By Outsourced
7. Middle East & Africa Peptide Therapeutics Market, by Synthesis Technology
  1. By Liquid Phase Peptide Synthesis (LPPS)
  2. By Solid Phase Peptide Synthesis (SPPS)
  3. By Hybrid Technology
8. Middle East & Africa Peptide Therapeutics Market, by Distribution Channel
  1. By Hospital Pharmacies
  2. By Retail Pharmacies
  3. By Online Pharmacies
9. Middle East & Africa Peptide Therapeutics Market, by Country
  1. GCC Countries
    1. GCC Countries Peptide Therapeutics Market, By Type
      1. By Branded Peptides
      2. By Generic Peptides
    2. GCC Countries Peptide Therapeutics Market, By Application
      1. By Metabolic Disorders
      2. By Cancer
      3. By Cardiovascular Disorders
      4. By Gastrointestinal Disorders
      5. By Central Nervous System Disorders
      6. By Respiratory Disorders
      7. By Pain Management
      8. By Rental Disorders
      9. By Dermatology
      10. By Other Applications
    3. GCC Countries Peptide Therapeutics Market, By Route of Administration
      1. By Parenteral
      2. By Oral
      3. By Other Routes of Administration
    4. GCC Countries Peptide Therapeutics Market, By Manufacturer Type
      1. By In-house
      2. By Outsourced
    5. GCC Countries Peptide Therapeutics Market, By Synthesis Technology
      1. By Liquid Phase Peptide Synthesis (LPPS)
      2. By Solid Phase Peptide Synthesis (SPPS)
      3. By Hybrid Technology
    6. GCC Countries Peptide Therapeutics Market, By Distribution Channel
      1. By Hospital Pharmacies
      2. By Retail Pharmacies
      3. By Online Pharmacies
  2. South Africa
    1. South Africa Peptide Therapeutics Market, By Type
      1. By Branded Peptides
      2. By Generic Peptides
    2. South Africa Peptide Therapeutics Market, By Application
      1. By Metabolic Disorders
      2. By Cancer
      3. By Cardiovascular Disorders
      4. By Gastrointestinal Disorders
      5. By Central Nervous System Disorders
      6. By Respiratory Disorders
      7. By Pain Management
      8. By Rental Disorders
      9. By Dermatology
      10. By Other Applications
    3. South Africa Peptide Therapeutics Market, By Route of Administration
      1. By Parenteral
      2. By Oral
      3. By Other Routes of Administration
    4. South Africa Peptide Therapeutics Market, By Manufacturer Type
      1. By In-house
      2. By Outsourced
    5. South Africa Peptide Therapeutics Market, By Synthesis Technology
      1. By Liquid Phase Peptide Synthesis (LPPS)
      2. By Solid Phase Peptide Synthesis (SPPS)
      3. By Hybrid Technology
    6. South Africa Peptide Therapeutics Market, By Distribution Channel
      1. By Hospital Pharmacies
      2. By Retail Pharmacies
      3. By Online Pharmacies
  3. Rest of Middle East & Africa
    1. Rest of Middle East & Africa Peptide Therapeutics Market, By Type
      1. By Branded Peptides
      2. By Generic Peptides
    2. Rest of Middle East & Africa Peptide Therapeutics Market, By Application
      1. By Metabolic Disorders
      2. By Cancer
      3. By Cardiovascular Disorders
      4. By Gastrointestinal Disorders
      5. By Central Nervous System Disorders
      6. By Respiratory Disorders
      7. By Pain Management
      8. By Rental Disorders
      9. By Dermatology
      10. By Other Applications
    3. Rest of Middle East & Africa Peptide Therapeutics Market, By Route of Administration
      1. By Parenteral
      2. By Oral
      3. By Other Routes of Administration
    4. Rest of Middle East & Africa Peptide Therapeutics Market, By Manufacturer Type
      1. By In-house
      2. By Outsourced
    5. Rest of Middle East & Africa Peptide Therapeutics Market, By Synthesis Technology
      1. By Liquid Phase Peptide Synthesis (LPPS)
      2. By Solid Phase Peptide Synthesis (SPPS)
      3. By Hybrid Technology
    6. Rest of Middle East & Africa Peptide Therapeutics Market, By Distribution Channel
      1. By Hospital Pharmacies
      2. By Retail Pharmacies
      3. By Online Pharmacies
Key Market Dynamics
1. Introduction
2. Market Drivers
3. Market Restraints
4. Market Opportunities
5. Porter's Five Forces Analysis
6. PEST Analysis
7. Regulatory Landscape
8. Technology Landscape
9. Regional Market Trends
COVID 19 Impact Analysis
1. Key strategies undertaken by companies to tackle COVID-19
2. Short term dynamics
3. Long term dynamics
Marketing Stratagy Analysis
1. Marketing Channel
2. Direct Marketing
3. Indirect Marketing
4. Marketing Channel Development Trends
Competative Landscape
1. Competition Matrix - 2021
2. Company Market Share Analysis - 2021
3. Key Company Activities, 2018 - 2021
4. Strategic Developments - Heat Map Analysis
5. Company Offering Evaluation
6. Company Regional Presence Evaluation
Company Profiles
1. Eli Lilly and Company (U.S.)
2. Pfizer Inc. (U.S.)
3. Amgen Inc. (U.S.)
4. Takeda Pharmaceutical Company Limited (Japan)
5. AstraZeneca PLC (UK)
6. Teva Pharmaceutical Industries Ltd. (Israel)
7. Sanofi (France)
8. F. Hoffmann-La Roche Ltd. (Switzerland)
9. Novartis AG (Switzerland)
10. Novo Nordisk A/S (Denmark)
11. GlaxoSmithKline PLC (UK)
12. Ironwood Pharmaceuticals Inc. (U.S.)
13. Radius Health Inc. (U.S.)
14. Ipsen Pharma (France)
Key Primary Respondents - VERBATIM
Discussion Guide
Customization Offered
Annexure
List of Figures
List of Tables
List of Abbreviations

FAQ

Frequently Asked Question

What is the global demand for Peptide Therapeutics in terms of revenue?

The global Peptide Therapeutics valued at USD 43.04 Billion in 2023 and is expected to reach USD 81.48 Billion in 2032 growing at a CAGR of 7.35%.

Which are the prominent players in the market?

The prominent players in the market are Eli Lilly and Company (U.S.), Pfizer Inc. (U.S.), Amgen Inc. (U.S.), Takeda Pharmaceutical Company Limited (Japan), AstraZeneca PLC (UK), Teva Pharmaceutical Industries Ltd. (Israel), Sanofi (France), F. Hoffmann-La Roche Ltd. (Switzerland), Novartis AG (Switzerland), Novo Nordisk A/S (Denmark), GlaxoSmithKline PLC (UK), Ironwood Pharmaceuticals Inc. (U.S.), Radius Health Inc. (U.S.), Ipsen Pharma (France).

At what CAGR is the market projected to grow within the forecast period?

The market is project to grow at a CAGR of 7.35% between 2024 and 2032.

What are the driving factors fueling the growth of the market.

The driving factors of the Peptide Therapeutics include
- Advancements in Production Processes Driving Growth

Which region accounted for the largest share in the market?

North America was the leading regional segment of the Peptide Therapeutics in 2023.

Peptide Therapeutics Market

Peptide Therapeutics Market - Global Industry Assessment & Forecast

Healthcare

Segments Covered

Snapshot

Customization Offered

FAQ

Frequently Asked Question

What is the global demand for Peptide Therapeutics in terms of revenue?

Which are the prominent players in the market?

At what CAGR is the market projected to grow within the forecast period?

What are the driving factors fueling the growth of the market.

Which region accounted for the largest share in the market?

Vantage Market Research

Products & Services

Media

Contact Us

Peptide Therapeutics Market

Peptide Therapeutics Market - Global Industry Assessment & Forecast

Healthcare

Segments Covered

Snapshot

Customization Offered

FAQ

Frequently Asked Question

What is the global demand for Peptide Therapeutics in terms of revenue?

Which are the prominent players in the market?

At what CAGR is the market projected to grow within the forecast period?

What are the driving factors fueling the growth of the market.

Which region accounted for the largest share in the market?

Related Reports

Request Sample Report for Peptide Therapeutics Market

Vantage Point Interactive Dashboard